Centum Electronics Ltd

- Centum Electronics raised Rs. 210 crores via a Qualified Institutional Placement (QIP) in the last quarter, indicating strong investor confidence. - Out of the raised amount, Rs. 115 crores are allocated for debt reduction, with Rs. 110 crores already repaid. - The remaining funds are allocated strategically for CAPEX and general corporate purposes. - There is no specific mention of any current or future new fundraising through debt or equity beyond this QIP in the call. - The company appears focused on utilizing existing raised funds effectively rather than planning fresh fundraising at this time.

- For FY '26, Centum plans to invest about Rs. 40 crores in CAPEX on a standalone basis. - The investment aims to augment capabilities and increase capacities across both BTS (Build-To-Spec) and EMS segments. - The procured equipment will be interchangeable between BTS and EMS operations. - Strategically, the company is focusing on cost optimization and operational improvements, especially in the French engineering services business. - Discussions are underway to address losses in the Canadian subsidiary with plans to complete any strategic transitions by September 2025. - Funds raised via QIP (Rs. 210 crores) have been partly utilized for debt reduction (Rs. 115 crores); remaining funds are allocated for CAPEX and general corporate purposes. - The company targets growth driven by ongoing strategic investments in defense and aerospace sectors.

- Consolidated revenue expected to grow at 18% to 20% annually. - Standalone entity projected to grow at over 25%. - Subsidiary revenues expected to remain roughly flat in the near term. - Build-To-Specification (BTS) and EMS businesses on standalone basis expected to grow at a blended rate of 25% to 28%. - BTS revenue targeted to increase significantly, with ambitions to reach Rs. 400-600 crores in 3-4 years. - Healthy order pipeline of approximately Rs. 2,000 crores in the next 3-4 years supports growth visibility. - Growth driven primarily by domestic defense and space sector, along with semiconductor equipment and biometric solutions areas. - Confident about sustaining healthy revenue growth due to strong demand, customer forecasts, and new product qualifications. - Margin improvement anticipated with operational efficiencies and cost optimization in subsidiaries.

- Consolidated revenue growth expected at 18% to 20%, driven by standalone entity growing over 25%. - Strong growth momentum in EMS and BTS segments at standalone level, with blended growth of 25% to 28%. - EBITDA margin on consolidated level expected around 10% if subsidiary issues resolved by September quarter. - Standalone EBITDA margin in Q4 FY25 was strong at 17.37%, indicating profitability improvements. - Focus on controlling costs in subsidiaries and improving operational efficiencies. - Order book of Rs. 1,736 crores with Rs. 1,330 crores standalone, supporting revenue growth and profitability. - Targeting healthy revenue growth and margin expansion by scaling build-to-spec (BTS) and EMS businesses. - Profit growth reflected by standalone net profit growth of 46% YoY in FY25. - Overall outlook positive with confidence in achieving growth and improved earnings in coming years.

- Total order book as of 31st March 2025 stands at Rs. 1,736 crores. - Standalone order book increased to Rs. 1,330 crores from Rs. 1,118 crores in the previous financial year. - Build-to-specification (BTS) order book standalone is Rs. 664 crores. - EMS order book standalone is Rs. 665 crores. - Order horizon varies: BTS executable over 2 to 2.5 years; EMS typically less than 12 months; Engineering services even shorter. - A healthy pipeline exists for bids targeting about Rs. 2,000 crores over 3-4 years, primarily in defense and aerospace. - Firm orders and customer forecasts provide visibility and reasonably secure demand. - Ongoing qualification of new customers expected to convert forecasts into firm purchase orders in coming quarters.